1. Home
  2. LPCN vs EDTK Comparison

LPCN vs EDTK Comparison

Compare LPCN & EDTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • EDTK
  • Stock Information
  • Founded
  • LPCN 1997
  • EDTK 2013
  • Country
  • LPCN United States
  • EDTK China
  • Employees
  • LPCN N/A
  • EDTK N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • EDTK Other Consumer Services
  • Sector
  • LPCN Health Care
  • EDTK Real Estate
  • Exchange
  • LPCN Nasdaq
  • EDTK Nasdaq
  • Market Cap
  • LPCN 16.1M
  • EDTK 15.6M
  • IPO Year
  • LPCN N/A
  • EDTK 2020
  • Fundamental
  • Price
  • LPCN $3.24
  • EDTK $0.81
  • Analyst Decision
  • LPCN Strong Buy
  • EDTK
  • Analyst Count
  • LPCN 1
  • EDTK 0
  • Target Price
  • LPCN $10.00
  • EDTK N/A
  • AVG Volume (30 Days)
  • LPCN 10.5K
  • EDTK 9.7K
  • Earning Date
  • LPCN 05-08-2025
  • EDTK 05-16-2025
  • Dividend Yield
  • LPCN N/A
  • EDTK N/A
  • EPS Growth
  • LPCN N/A
  • EDTK N/A
  • EPS
  • LPCN N/A
  • EDTK N/A
  • Revenue
  • LPCN $3,674,834.00
  • EDTK $624,365.00
  • Revenue This Year
  • LPCN N/A
  • EDTK N/A
  • Revenue Next Year
  • LPCN N/A
  • EDTK N/A
  • P/E Ratio
  • LPCN N/A
  • EDTK N/A
  • Revenue Growth
  • LPCN N/A
  • EDTK N/A
  • 52 Week Low
  • LPCN $2.75
  • EDTK $0.84
  • 52 Week High
  • LPCN $11.79
  • EDTK $1.27
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 49.75
  • EDTK 26.44
  • Support Level
  • LPCN $3.12
  • EDTK $1.02
  • Resistance Level
  • LPCN $3.60
  • EDTK $1.08
  • Average True Range (ATR)
  • LPCN 0.23
  • EDTK 0.05
  • MACD
  • LPCN 0.01
  • EDTK -0.02
  • Stochastic Oscillator
  • LPCN 40.12
  • EDTK 0.00

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About EDTK Skillful Craftsman Education Technology Limited

Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.

Share on Social Networks: